Evolent Health
EVH
218 hedge funds and large institutions have $2.79B invested in Evolent Health in 2022 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 87 increasing their positions, 75 reducing their positions, and 24 closing their positions.
54% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 24
42% more call options, than puts
Call options by funds: $9.9M | Put options by funds: $6.97M
26% more capital inflows, than outflows
Capital inflows: $222M | Capital outflows: $175M
16% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 75
5% more funds holding
Funds holding: 207 → 218 (+11)
0.53% more ownership
Funds ownership: 94.74% → 95.26% (+0.53%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$25.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.4M |
| 3 |
Millennium Management
New York
|
+$15.2M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14.7M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$14.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Great Lakes Advisors
Chicago,
Illinois
|
-$21.8M |
| 2 |
Eagle Asset Management
St Petersburg,
Florida
|
-$21.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.9M |
| 4 |
Engaged Capital
Newport Beach,
California
|
-$17.9M |
| 5 |
Granahan Investment Management
Waltham,
Massachusetts
|
-$12.4M |
EVH Hedge Fund Activity: Q1 2022 in Review
218 of the 6,365 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2022, worth a combined $2.79B — up 19% from $2.34B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new EVH positions and 24 closed out — a net gain of 13 holders — while 87 added to existing stakes and 75 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $25.9M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $21.8M sold.
- 218 institutional investors held Evolent Health (EVH) as of Q1 2022, up from 207 in Q4 2021.
- Funds reported $2.79B of Evolent Health stock for Q1 2022, up 19% quarter-over-quarter.
- 37 funds opened new Evolent Health positions in Q1 2022 and 24 closed out, a net change of +13 holders.
- The largest Evolent Health buyer in Q1 2022 was Point72 Asset Management, an estimated $25.9M added.
- The largest Evolent Health seller in Q1 2022 was Great Lakes Advisors, an estimated $21.8M sold.
Based on aggregated 13F filings for Q1 2022.